https://idwiki.org/index.php?action=history&feed=atom&title=Maribavir
Maribavir - Revision history
2026-04-28T18:21:07Z
Revision history for this page on the wiki
MediaWiki 1.43.8
https://idwiki.org/index.php?title=Maribavir&diff=5744&oldid=prev
Aidan: Text replacement - "([Ss])olid-organ" to "$1olid organ"
2020-08-07T01:03:12Z
<p>Text replacement - "([Ss])olid-organ" to "$1olid organ"</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:03, 7 August 2020</td>
</tr><tr>
<td colspan="2" class="diff-lineno">Line 1:</td>
<td colspan="2" class="diff-lineno">Line 1:</td>
</tr>
<tr>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Class is benzimidazole riboside</div></td>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Class is benzimidazole riboside</div></td>
</tr>
<tr>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Mechanism of action is inhibition of UL97-mediated phosphorylation of nuclear lamin A/C</div></td>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Mechanism of action is inhibition of UL97-mediated phosphorylation of nuclear lamin A/C</div></td>
</tr>
<tr>
<td class="diff-marker" data-marker="−"></td>
<td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* Main indication is [[CMV]] prophylaxis in solid<del style="font-weight: bold; text-decoration: none;">-</del>organ transplant</div></td>
<td class="diff-marker" data-marker="+"></td>
<td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* Main indication is [[CMV]] prophylaxis in solid<ins style="font-weight: bold; text-decoration: none;"> </ins>organ transplant</div></td>
</tr>
<tr>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td>
</tr>
<tr>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Further Reading ==</div></td>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Further Reading ==</div></td>
</tr>
<tr>
<td class="diff-marker" data-marker="−"></td>
<td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid<del style="font-weight: bold; text-decoration: none;">-</del>organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study. ''Clin Infect Dis''. 2019;68(8):1255–1264. DOI: [https://doi.org/10.1093/cid/ciy706 10.1093/cid/ciy706]</div></td>
<td class="diff-marker" data-marker="+"></td>
<td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid<ins style="font-weight: bold; text-decoration: none;"> </ins>organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study. ''Clin Infect Dis''. 2019;68(8):1255–1264. DOI: [https://doi.org/10.1093/cid/ciy706 10.1093/cid/ciy706]</div></td>
</tr>
<tr>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td>
</tr>
<tr>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Antivirals]]</div></td>
<td class="diff-marker"></td>
<td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Antivirals]]</div></td>
</tr>
<!-- diff cache key site7_mediawiki:diff:1.41:old-3732:rev-5744:wikidiff2=table:1.13.0:bc2a06be -->
</table>
Aidan
https://idwiki.org/index.php?title=Maribavir&diff=3732&oldid=prev
Aidan: Created page with "* Class is benzimidazole riboside * Mechanism of action is inhibition of UL97-mediated phosphorylation of nuclear lamin A/C * Main indication is CMV prophylaxis in solid-o..."
2020-03-13T00:21:39Z
<p>Created page with "* Class is benzimidazole riboside * Mechanism of action is inhibition of UL97-mediated phosphorylation of nuclear lamin A/C * Main indication is <a href="/CMV" class="mw-redirect" title="CMV">CMV</a> prophylaxis in solid-o..."</p>
<p><b>New page</b></p><div>* Class is benzimidazole riboside<br />
* Mechanism of action is inhibition of UL97-mediated phosphorylation of nuclear lamin A/C<br />
* Main indication is [[CMV]] prophylaxis in solid-organ transplant<br />
<br />
== Further Reading ==<br />
* Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study. ''Clin Infect Dis''. 2019;68(8):1255–1264. DOI: [https://doi.org/10.1093/cid/ciy706 10.1093/cid/ciy706]<br />
<br />
[[Category:Antivirals]]</div>
Aidan